Alterity Therapeutics Ltd
F:PBN0
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Alterity Therapeutics Ltd
F:PBN0
|
AU |
|
M
|
Mount Burgess Mining NL
OTC:MTBMF
|
AU |
|
Bactech Environmental Corp
OTC:BCCEF
|
CA |
|
E
|
Enma Al-Rawabi Co
SAU:9521
|
SA |
|
Shikoku Chemicals Corp
TSE:4099
|
JP |
|
Electra Battery Materials Corp
XTSX:ELBM
|
CA |
|
K
|
Klingelnberg AG
SWB:2MK
|
CH |
|
I
|
International Carbide Technology Co Ltd
TPEX:4754
|
TW |
|
Zhaoheng Hydropower Co Ltd
OTC:ZHYLF
|
HK |
|
B
|
Bouygues SA
SWB:BYG
|
FR |
|
F
|
Falcon Oil & Gas Ltd
F:FAC
|
IE |
|
S
|
Stelmine Canada Ltd
OTC:STHFF
|
CA |
|
Basilea Pharmaceutica AG
F:PK5
|
CH |
|
I
|
Imbalie Beauty Ltd
JSE:BKI
|
ZA |
|
V
|
Veritec Inc
OTC:VRTC
|
US |
Bankruptcy Probability
Alterity Therapeutics Ltd's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Alterity Therapeutics Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AU |
|
Alterity Therapeutics Ltd
ASX:ATH
|
115.3m AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
440.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
224.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
171.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
128.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
83.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
53.5B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
64.9B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Alterity Therapeutics Ltd's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Alterity Therapeutics Ltd has total debt of 65.5k AUD. This includes both short-term (0 AUD) and long-term (65.5k AUD) debt.
You can find a full breakdown on its Balance Sheet.
